Conversion of intravenous to oral antibiotic therapy in an adult intensive care unit

Objective: To identify the possibility of alteration of intravenous (IV) to oral (PO) therapy for ampicillin/sulbactam and cefuroxime in adult patients treated in intensive care units (ICUs), and to describe the profile and consumption of antimicrobials prescribed for these patients. Methods: A des...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Deise L. LOCATELLI, Carine R. BLATT, Maria C. WERLANG
Formato: article
Lenguaje:EN
PT
Publicado: Sociedade Brasileira de Farmácia Hospitalar e Serviços de Saúde 2020
Materias:
Acceso en línea:https://doaj.org/article/43c228d28980434b9df8757845532380
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:43c228d28980434b9df8757845532380
record_format dspace
spelling oai:doaj.org-article:43c228d28980434b9df87578455323802021-11-28T02:44:48ZConversion of intravenous to oral antibiotic therapy in an adult intensive care unit10.30968/rbfhss.2020.113.04442179-59242316-7750https://doaj.org/article/43c228d28980434b9df87578455323802020-08-01T00:00:00Zhttps://www.rbfhss.org.br/sbrafh/article/view/444https://doaj.org/toc/2179-5924https://doaj.org/toc/2316-7750 Objective: To identify the possibility of alteration of intravenous (IV) to oral (PO) therapy for ampicillin/sulbactam and cefuroxime in adult patients treated in intensive care units (ICUs), and to describe the profile and consumption of antimicrobials prescribed for these patients. Methods: A descriptive, cross-sectional, and retrospective documentary study based on the analysis of electronic prescriptions and data from the electronic medical record of patients admitted to adult intensive care units in two hospitals, from July to August 2019. The consumption of antimicrobials was measured using the Anatomical Therapeutic Chemical/Daily Defined Dose (ATC/DDD) methodology per 100 beds-day. Results: Of the patients admitted to the study units, 23 (5.5%) received ampicillin/sulbactam or cefuroxime; the time of the ampicillin/sulbactam treatment was 7.25 (±2.07) days and, with cefuroxime, 8 (±1.73) days; 3 (13%) of the patients followed were eligible to switch therapy or sequential therapy, there was no physician acceptance of the conversion recommendation. The highest consumption was observed in the penicillins therapeutic group (112.5 DDD/100 beds-day) and meropenem drug (68.8 DDD/100 beds-day). Conclusions: Antimicrobial use is high in ICUs, which can be related to the clinical complexity and to the microbiological profile of the patients. The practice of converting IV antibiotic therapy to PO in critically ill patients was not present in this study; however, its use can contribute to patient safety. Deise L. LOCATELLICarine R. BLATTMaria C. WERLANGSociedade Brasileira de Farmácia Hospitalar e Serviços de SaúdearticlePublic aspects of medicineRA1-1270Pharmacy and materia medicaRS1-441Therapeutics. PharmacologyRM1-950ENPTRevista Brasileira de Farmácia Hospitalar e Serviços de Saúde, Vol 11, Iss 3 (2020)
institution DOAJ
collection DOAJ
language EN
PT
topic Public aspects of medicine
RA1-1270
Pharmacy and materia medica
RS1-441
Therapeutics. Pharmacology
RM1-950
spellingShingle Public aspects of medicine
RA1-1270
Pharmacy and materia medica
RS1-441
Therapeutics. Pharmacology
RM1-950
Deise L. LOCATELLI
Carine R. BLATT
Maria C. WERLANG
Conversion of intravenous to oral antibiotic therapy in an adult intensive care unit
description Objective: To identify the possibility of alteration of intravenous (IV) to oral (PO) therapy for ampicillin/sulbactam and cefuroxime in adult patients treated in intensive care units (ICUs), and to describe the profile and consumption of antimicrobials prescribed for these patients. Methods: A descriptive, cross-sectional, and retrospective documentary study based on the analysis of electronic prescriptions and data from the electronic medical record of patients admitted to adult intensive care units in two hospitals, from July to August 2019. The consumption of antimicrobials was measured using the Anatomical Therapeutic Chemical/Daily Defined Dose (ATC/DDD) methodology per 100 beds-day. Results: Of the patients admitted to the study units, 23 (5.5%) received ampicillin/sulbactam or cefuroxime; the time of the ampicillin/sulbactam treatment was 7.25 (±2.07) days and, with cefuroxime, 8 (±1.73) days; 3 (13%) of the patients followed were eligible to switch therapy or sequential therapy, there was no physician acceptance of the conversion recommendation. The highest consumption was observed in the penicillins therapeutic group (112.5 DDD/100 beds-day) and meropenem drug (68.8 DDD/100 beds-day). Conclusions: Antimicrobial use is high in ICUs, which can be related to the clinical complexity and to the microbiological profile of the patients. The practice of converting IV antibiotic therapy to PO in critically ill patients was not present in this study; however, its use can contribute to patient safety.
format article
author Deise L. LOCATELLI
Carine R. BLATT
Maria C. WERLANG
author_facet Deise L. LOCATELLI
Carine R. BLATT
Maria C. WERLANG
author_sort Deise L. LOCATELLI
title Conversion of intravenous to oral antibiotic therapy in an adult intensive care unit
title_short Conversion of intravenous to oral antibiotic therapy in an adult intensive care unit
title_full Conversion of intravenous to oral antibiotic therapy in an adult intensive care unit
title_fullStr Conversion of intravenous to oral antibiotic therapy in an adult intensive care unit
title_full_unstemmed Conversion of intravenous to oral antibiotic therapy in an adult intensive care unit
title_sort conversion of intravenous to oral antibiotic therapy in an adult intensive care unit
publisher Sociedade Brasileira de Farmácia Hospitalar e Serviços de Saúde
publishDate 2020
url https://doaj.org/article/43c228d28980434b9df8757845532380
work_keys_str_mv AT deisellocatelli conversionofintravenoustooralantibiotictherapyinanadultintensivecareunit
AT carinerblatt conversionofintravenoustooralantibiotictherapyinanadultintensivecareunit
AT mariacwerlang conversionofintravenoustooralantibiotictherapyinanadultintensivecareunit
_version_ 1718408436771717120